Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001274173-25-000216·Janus Henderson Group Ltd.
Schedule 13G ownership disclosure
MEREO BIOPHARMA GROUP PLC
American Depositary Shares · CUSIP: 589492107
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- JANUS HENDERSON GROUP PLC
Shares: 17,688,592 · Class: 11.1%
- Janus Henderson Biotech Innovation Master Fund Ltd
Shares: 15,203,597 · Class: 9.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001274173-25-000216
- Form type
- SCHEDULE 13G/A
- Filer
- Janus Henderson Group Ltd.
- CIK
- CIK 1274173
- Filed
- Aug 14, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership